Dinaciclib in Treating Patients With Stage IV Melanoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Immunocore Ltd
National Cancer Institute (NCI)
Thomas Jefferson University
Seagen Inc.
IDEAYA Biosciences
Centre Oscar Lambret
Eastern Cooperative Oncology Group
Novartis
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Ohio State University Comprehensive Cancer Center
University of California, Irvine
NYU Langone Health
Pfizer
Merck Sharp & Dohme LLC
Philogen S.p.A.
Hoffmann-La Roche
M.D. Anderson Cancer Center
Jules Bordet Institute
M.D. Anderson Cancer Center
Endeavor Biomedicines, Inc.
University Health Network, Toronto
Hanmi Pharmaceutical Company Limited
Georgetown University
Thomas Jefferson University
Genmab
Psyence Australia Pty Ltd
Suzhou BlueHorse Therapeutics Co., Ltd.
M.D. Anderson Cancer Center
Melanoma Institute Australia
University of Pittsburgh
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
Melanoma Institute Australia
Abramson Cancer Center at Penn Medicine
University Hospital, Caen
M.D. Anderson Cancer Center